Filing Details
Serina Therapeutics, Inc. (NYSE:SER) filed a Form 8-K with the Securities and Exchange Commission on October 09, 2026, disclosing a material event.
8k filedNYSE:SER
Serina Therapeutics, Inc. (SER) Reports Material Event to SEC
Serina Therapeutics, Inc. (NYSE:SER) filed a Form 8-K with the Securities and Exchange Commission on October 09, 2026, disclosing a material event.
At publication ·
What changed
Serina Therapeutics, Inc. (NYSE:SER) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Serina Therapeutics filed a Form 8-K with the SEC on October 09, 2026, disclosing a material event requiring shareholder disclosure.
- The company's stock trades at $2.00 per share with a market capitalization of $33.5 million.
- Material events reported via 8-K filings include leadership changes, agreements, acquisitions, asset sales, or changes to financial guidance.
Market Context
Serina Therapeutics, Inc.'s stock currently trades at $2.00 with a market capitalization of $33.5M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Serina Therapeutics, Inc.'s stock.
All SEC filings for Serina Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View SER Stock Page
Frequently Asked Questions
Where can I read SER's SEC filings?
Browse all filings on our SER SEC filings page.
What types of SEC filings does Serina Therapeutics, Inc. file?
Public companies like Serina Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.